Please select the option that best describes you:
How would you treat lymphoplasmacytic lymphoma (LPL) with a non-IgM paraprotein?
Does your treatment approach differ from Waldenstrom's Macroglobulinemia?
Does the presence/absence of a MYD88 L265P and/or CXCR4 mutation change your treatment approach?
Answer from: Medical Oncologist at Academic Institution
My treatment approach would be similar to those with IgM LPL (WM).
Sign in or Register to read more